PedAM
Pediatric Disease Annotations & Medicines
| Disease | epilepsy |
| Phenotype | C0041341|tuberous sclerosis |
| Sentences | 32 |
| PubMedID- 20041940 | The natural history of epilepsy in tuberous sclerosis complex. |
| PubMedID- 25591831 | Conclusion: various preclinical models provide substantial evidence for the role of mtor inhibition in the treatment of epilepsy in individuals with tuberous sclerosis complex. |
| PubMedID- 19369101 | epilepsy associated with tuberous sclerosis complex (tsc) is characterized by early onset and intractable seizures in the majority of children. |
| PubMedID- 23219029 | Clobazam therapy of refractory epilepsy in tuberous sclerosis complex. |
| PubMedID- 23861807 | They also found associations between autistic traits and epilepsy in patients with tuberous sclerosis. |
| PubMedID- 22019663 | Multimodal approach in the surgical treatment of refractory epilepsy associated with tuberous sclerosis complex: a series of three cases. |
| PubMedID- 21481739 | Cortical tubers, cognition, and epilepsy in tuberous sclerosis. |
| PubMedID- 26067126 | Treatment of epilepsy associated with tuberous sclerosis remains a major challenge, with more than 60% of patients having ongoing seizures. |
| PubMedID- 21959128 | Purpose: to elucidate the functional characteristics of cortical tubers that might be responsible for epilepsy in tuberous sclerosis complex (tsc), proton magnetic resonance spectroscopy ((1)h-mrs) and [123i] iomazenil (123i-imz) single photon emission computed tomography (spect) were performed. |
| PubMedID- 24379984 | Clinical trials are ongoing to further examine the effects of everolimus on epilepsy associated with tuberous sclerosis complex. |
| PubMedID- 24044547 | epilepsy associated with tuberous sclerosis generally begins during the first year of life and, in most patients, in the first few months. |
| PubMedID- 26060906 | epilepsy in tuberous sclerosis: phenotypes, mechanisms, and treatments. |
| PubMedID- 22247914 | Clinical progress of epilepsy in children with tuberous sclerosis: prognostic factors for seizure outcome. |
| PubMedID- 23883617 | Abnormal inhibitory circuits in cortical tubers of tuberous sclerosis, associated with refractory epilepsy, are accompanied by aberrant expression of parvalbumin and calbindin d28k in the dysplastic cortex [226]. |
| PubMedID- 24698169 | Background/purpose: to clarify the relationship between neuroimaging findings, neuropsychiatric comorbidities, and epilepsy in patients with tuberous sclerosis complex (tsc) in taiwan. |
| PubMedID- 25030328 | epilepsy in newborns with tuberous sclerosis complex. |
| PubMedID- 23798472 | Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. |
| PubMedID- 20636971 | Can we change the course of epilepsy in tuberous sclerosis complex. |
| PubMedID- 26539097 | Other studies reported results from homogeneous patient groups with various locations of the epileptogenic zone, e.g., epilepsy in tuberous sclerosis (okanishi et al., 2014) and neocortical epilepsy (cho et al., 2014). |
| PubMedID- 23743820 | Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86. |
| PubMedID- 22695035 | Management of epilepsy associated with tuberous sclerosis complex (tsc): clinical recommendations. |
| PubMedID- 25360852 | Object: tuberous sclerosis complex (tsc) with medically refractory epilepsy is characterized by multifocal brain abnormalities, traditionally indicating poor surgical candidacy. |
| PubMedID- 22142783 | Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis. |
| PubMedID- 20682200 | Vagus nerve stimulation for refractory epilepsy in tuberous sclerosis. |
| PubMedID- 22983234 | Treatment of epilepsy in tuberous sclerosis is similar to epilepsy resulting from other cases and includes anticonvulsant medications, the epilepsy surgery, the vagus nerve stimulation and the ketogenic diet. |
| PubMedID- 26046563 | epilepsy in children with tuberous sclerosis complex: chance of remission and response to antiepileptic drugs. |
| PubMedID- 24304436 | Purpose: prevalence and long-term outcome of epilepsy in tuberous sclerosis complex (tsc) is reported to be variable, and the reasons for this variability are still controversial. |
| PubMedID- 23703058 | Conclusions: epilepsy in tuberous sclerosis is relatively benign and an acceptable degree of control is achieved in most cases with a number of the antiepileptic drugs recommended in the treatment guidelines. |
| PubMedID- 25847341 | Its role in the treatment of epilepsy in individuals with tuberous sclerosis complex (tsc) has yet to be determined. |
| PubMedID- 24556736 | Target-oriented treatments such as rapamycin and everolimus are currently under clinical investigation to prevent epilepsy in patients with tuberous sclerosis. |
| PubMedID- 22000822 | Effective everolimus treatment of inoperable, life-threatening subependymal giant cell astrocytoma and intractable epilepsy in a patient with tuberous sclerosis complex. |
| PubMedID- 23250840 | epilepsy in tuberous sclerosis complex. |
Page: 1